zintick

← Actuate Therapeutics (ACTU)

Actuate Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KOct. 30, 2026, 4:05 p.m. ETView on SEC.govOur explainer

    Delisting notice / failure to meet listing standard

    AI summary, unreviewedActuate Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice, Adding to Existing MVLS Non-Compliance

  • 8-KOct. 28, 2026, 5:17 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Other events · Financial statements and exhibits

    AI summary, unreviewedActuate Therapeutics Prices $11.0 Million Public Offering at $0.71 per Share-and-Warrant Set, Closes for Net Proceeds of About $9.96 Million